LABORATOIRES DIEPHARMEX SA
Mr Bruce BONOChief Commercial Officer
LABORATOIRES URGO HEALTHCARE
Short Company Description:
Urgo Healthcare (Turnover of 156 M€, the Self Care Division of the privately owned URGO Group, 589 M€ / 3180 employees), has leading market positions in France and on international markets (81M€ is done on International Markets through our 22 subsidiaries and exclusive distributors).
Urgo Healthcare has a portofolio of 12 brands of which 4 are global:
URGO in First Aid
HUMEX and HUMER in Cough & Cold and Allergy
ALVITYL in Multivitamins
Other brands are AGAVE, ALPHREMA, MORDEX, SONODOR, NOVAFIX, SONALTO, INOTYOL and GOVITAL.
We are interested in:
Urgo Healthcare is interested in Licencing-In products (range extensions and breakthrough innovations) for its different brands to be promoted in France and its network of 80 countries.
We have the expertise in different types of regulatory status, whether OTC MA Drugs, Medical Devices, Electrical Devices, Biocides, Food Supplements or Cosmetics. We focus on self-medication products with strong clinical evidence.
We are mainly interested in the following products:
- Cough&Cold, ENT and Allergy OTC Drugs (based on chemical or natural ingredients)
- Cough&Cold, ENT and Allergy Medical Devices (based on natural ingredients)
- First aid (Ex: advanced wound care plasters, stop bleeding, burn injuries, innovative antiseptic solutions, insect bites, blisters, Filmogel Technology®)
- Pain management products (Electrotherapy devices, Creams, Gels, Hot&Cold Patches and Sport Injuries)
- Oral Care & Dental care
- Skin care (Including baby care)
- Foot care
- Gynecology care (vaginal dryness & infections, Pelvis pain, infertility …)
- Food Supplement for well being and vitality for all the family (Ex: Probiotics)
- Hearing discomfort devices (hearing loss, tinnitus …)
Mr Pascal AUZIEREStrategic Business Development Director
Mr Hugo METIVIERBUSINESS DEVELOPMENT MANAGER
We are offering a full service (MA Dossier + Supply) to partners willing to create and complement their range with products that we offer.
Among others, we are working with multinational companies such as Servier, Mylan, Teva, BMS, Sanofi, Sandoz which appreciate our full service reactivity and quality.
Liberty Pharma offers several kind of products. Our Product list, available on demand, features :
- Medical mouthwashes
- Cough and cold products : pharmaceutical, phytotherapy, medical device and also food supplement
- Gastro-enterology products : both pharmaceutical and phytotherapy
- Venous pathologies : Food supplement range
- Dermatology : Scabies treatment
Each dossier is fully developed internally and is available to be audited in our online platform. We are looking for partners interested by the MA Dossiers / finished products that we offer, with a supply full service in order to launch innovative and unique products or to complete an existing range.
Our standard business model is open to discussion but normally we sell directly MA Dossiers, to our partners, combined with a long-term supply contract.
We don't have any trademarks or sales force, nor interest in licensing-in.
Dr Maxime HassidExport Director
LTS Lohmann Therapie-Systeme AG
Mrs Klaudia HaczkiewiczHead of Business Development
Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and the EU, with a robust pipeline of 30 drug candidates in China and more than 10 drug candidates overseas. The company currently has a number of new drugs and new formulations in the central nervous system and oncology therapeutic areas under study in the U.S. and the EU. Luye Pharma is a global cutting edge company in terms of research into new drug delivery technologies, such as microspheres, liposomes and transdermal drug delivery systems. The company is forward looking, with strategic development of innovative new compounds and antibodies, gene & cell therapies and smart formulations.
Luye Pharma has set up 7 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. The company offers more than 30 products covering the 4 largest and fastest growing therapeutic areas — oncology, cardiovascular, metabolism and central nervous system, with business conducted in over 80 countries and regions around the world, including the largest pharmaceutical markets - China, the U.S., the EU and Japan, as well as fast growing emerging markets.